CytRx Corp (NASDAQ:CYTR)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CYTR

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CYTR

  • Market Cap$10.430m
  • SymbolNASDAQ:CYTR
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS2328286081

Company Profile

CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).

Latest CYTR news

Currently there for this company. Visit our news hub for other news .